NYSE - Delayed Quote USD

Stevanato Group S.p.A. (STVN)

Compare
19.62 +1.35 (+7.39%)
At close: November 21 at 4:00 PM EST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Franco Stevanato CEO & Executive Chairman -- -- 1973
Mr. Marco Dal Lago Chief Financial Officer -- -- 1973
Mr. Ugo Gay Chief Operations Officer -- -- 1965
Ms. Lisa Miles Chief Communication Officer & Senior VP of Investor Relations -- -- --
Mr. Paolo De Fabritiis Chief HR Officer -- -- --
Mr. Mauro Stocchi Chief Business Officer -- -- 1966
Mr. Riccardo Butta President of Americas -- -- 1965

Stevanato Group S.p.A.

Via Molinella, 17
Piombino Dese, PD 35017
Italy
39 04 99 31 811 https://www.stevanatogroup.com
Sector:?
Healthcare
Full Time Employees:?
5,635

Description

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Corporate Governance

Stevanato Group S.p.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 5, 2024 at 11:30 AM UTC

Stevanato Group S.p.A. Earnings Date

Recent Events

November 19, 2024 at 9:00 AM UTC

at Jefferies London Healthcare Conference

November 14, 2024 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

November 12, 2024 at 7:00 PM UTC

at UBS Global Healthcare Conference

November 5, 2024 at 1:30 PM UTC

Q3 2024 Earnings Call

November 5, 2024 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

September 18, 2024 at 1:10 PM UTC

at Bank of America Global Healthcare Conference

September 6, 2024 at 11:00 AM UTC

at Morgan Stanley Global Healthcare Conference

September 4, 2024 at 12:00 AM UTC

S-8 POS: Offering Registrations

August 14, 2024 at 12:00 AM UTC

6-K: Corporate Changes & Voting Matters

August 6, 2024 at 12:30 PM UTC

Q2 2024 Earnings Call

Related Tickers